Our Strategies to Deliver Value

Johnson & Johnson is committed to developing procurement relationships based on trust. We drive growth while maintaining the highest standards through industry-leading supplier innovation, quality and reliability.

Growth & Innovation

We aim to own and shape a diverse supplier base that delivers high quality, compliant and reliable products and services.

Our suppliers are encouraged to source innovative solutions, and deliver new business models that contribute to our mutual objectives for growth and streamlined processes. We embrace new technology whenever it may help us meet the needs of our patients and consumers.
Investing in Our Future

We track new market developments and seek suppliers who understand emerging trends and plan their business accordingly. We forge long-term relationships with organizations that collaborate with us to successfully bring their innovations to the marketplace.

We follow a procurement approach that is rooted in Our Credo. We strive to obtain the highest-quality products and services at a fair cost, representing the best overall value for our companies.
Global Diversity, Citizenship and Sustainability

Embracing our role as an industry leader, Johnson & Johnson shapes and upholds the highest standards for responsible sourcing and corporate citizenship.

We further differentiate Johnson & Johnson by working with suppliers to accelerate environmental and social improvements across the value chain. We anticipate and manage risk, and ensure compliance with all procurement policies and processes.
Develop Our Diverse, Global Supply Base

We build and develop a global group of suppliers that reflects the diversity of our patients and customers, and our commitment to inclusion. The Supplier Diversity Program is designed to ensure that businesses of diverse backgrounds and ownership have the opportunity to become valued suppliers.

Since starting our Supplier Diversity Program in 1998, our total spending with small businesses and diverse-owned suppliers has been over one billion dollars annually.

8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine

As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.

ON NOW

From Lab to Vaccine Vial: The Historic Manufacturing Journey of Johnson & Johnson's Janssen COVID-19 Vaccine

As the U.S. government announces an agreement between Johnson & Johnson and Merck to collaborate on vaccine production, we trace all the steps it takes—from growing cells in a bioreactor to prepping palettes with high-tech track-and-trace technology—to develop and manufacture a vaccine during a pandemic.

ON NOW

Johnson & Johnson Chairman and CEO Appears at the White House to Discuss the Company's Collaboration with Merck and Future Vaccine Production

Learn more about the event, Johnson & Johnson's historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.

ON NOW